查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1578788

口服避孕药市场：按类型、年龄层、类别、分布 - 全球预测 2025-2030

Oral Contraceptive Pills Market by Type (Combination Pill, Continuous/Extended Pill, Progesterone Pill), Age Group (15-24, 25-34, 35-44), Category, Distribution - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年口服避孕药市值为173.3亿美元，预计到2024年将达到183.6亿美元，复合年增长率为6.76%，到2030年将达到274.1亿美元。

口服避孕药 (OCP) 市场包括旨在避孕和管理荷尔蒙失衡的产品，包括防止排卵的雌激素和黄体素组合。对 OCP 的需求在于其在为女性提供生育选择和有效管理多囊性卵巢症候群 (PCOS) 和子宫内膜异位症等疾病方面发挥的作用。 OCP 主要应用于女性健康领域，由医疗保健提供者、零售药局和线上平台部署。最终用户范围从优先考虑便利和隐私的个人到专注于综合女性健康服务的医疗保健系统。

主要市场统计
基准年[2023] 173.3亿美元
预测年份 [2024] 183.6亿美元
预测年份 [2030] 274.1亿美元
复合年增长率（%） 6.76%

关键的成长要素包括避孕药具意识和接受度的提高、支持计划生育的社会规范的改变以及对更个人化医疗保健的需求迅速增加。专注于最大限度地减少副作用、延长保质期以及提供口服药物以外的选择的技术创新带来了巨大的机会。企业应利用数位健康领域的技术进步，为虚拟咨询和个人化医疗提供平台。新兴市场，尤其是都市化不断提高、健康教育机会不断增加的发展中地区，还有开拓的潜力。与医疗机构的策略联盟进一步提高了市场渗透率和消费者信任度。

然而，该市场面临一些限制，例如某些地区的道德和政治反对、长期使用相关的潜在健康风险以及阻碍用户的副作用等。监管障碍也是一个重大挑战，严格的核准常常会延后产品的发布。研究非荷尔蒙避孕方案并加深我们对荷尔蒙对不同族群影响的了解，为创新铺路。最后，向永续性和环境责任的转变，例如生物分解性包装的开发，符合全球环境趋势并开拓了新市场。平衡成长需要应对这些复杂性，同时跟上技术和监管进步的步伐。了解消费者回馈并相应调整您的策略可以极大地提高您的市场地位和成长预测。

市场动态：揭示快速发展的口服避孕药市场的关键市场洞察

供需的动态交互作用正在改变口服避孕药市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 意外怀孕导致收养人数增加
    • 政府和非政府组织为普及避孕药具所做的努力
    • 性行为感染传染病 (STD) 增加
  • 市场限制因素
    • 避孕药对健康的不良影响
  • 市场机会
    • 口服避孕药处方的进展
    • 透过远端医疗服务和政府的有利核准改善避孕措施
  • 市场挑战
    • 有关药丸使用和产品行销问题的安全和社会问题

波特五力：驾驭口服避孕药市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解口服避孕药市场的外部影响

外部宏观环境因素在塑造口服避孕药市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解口服避孕药市场的竞争格局

对口服避孕药市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵口服避孕药市场供应商的绩效评估

FPNV定位矩阵是评估口服避孕药市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划口服避孕药市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，口服避孕药市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 意外怀孕导致收养增加
      • 政府和非政府组织努力普及避孕药具
      • 性行为感染传染病（STD）盛行率增加
    • 抑制因素
      • 避孕药具对健康的不良影响
    • 机会
      • 口服避孕药配方的进展
      • 透过远端医疗服务和政府核准改善避孕措施
    • 任务
      • 有关锭剂使用和产品行销问题的安全和社会问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章口服避孕药市场：依类型

  • 复方丸
  • 延续/延长药丸
  • 黄体酮丸

第七章口服避孕药市场：依年龄组

  • 15-24
  • 25-34
  • 35-44
  • 45岁以上

第八章口服避孕药市场：依类别

  • 品牌
  • 非专利的

第九章 口服避孕药市场经销商

  • 离线
  • 在线的

第10章美洲口服避孕药市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太口服避孕药市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲口服避孕药市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbvie Inc.
  • Acme Generics Pvt. Ltd.
  • Afaxys, Inc.
  • Agile Therapeutics, Inc.
  • Amneal Pharmaceuticals LLC
  • Aurobindo Pharma Limited
  • Azesto Impex Private Limited
  • Bayer AG
  • HLL Lifecare Limited
  • Insud Pharma
  • Johnson & Johnson Services, Inc.
  • Lupin Limited
  • Mankind Pharma Ltd.
  • Mayne Pharma Group Limited
  • Merck & Co. Inc.
  • Mithra Pharmaceuticals, SA
  • Mylan NV
  • Perrigo Company PLC
  • Pfizer Inc.
  • Piramal Pharma Solutions
  • Sanofi SA
  • Syzygy Healthcare Solutions LLC
  • Teva Pharmaceuticals Industries Ltd.
  • TherapeuticsMD, Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-4676B64E6B2E

The Oral Contraceptive Pills Market was valued at USD 17.33 billion in 2023, expected to reach USD 18.36 billion in 2024, and is projected to grow at a CAGR of 6.76%, to USD 27.41 billion by 2030.

The market for oral contraceptive pills (OCPs) encompasses products designed for birth control and the management of hormonal imbalances, involving combinations of estrogen and progestin hormones, which prevent ovulation. The necessities of OCPs lie in their role in empowering women with reproductive choice and effectively managing conditions such as polycystic ovary syndrome (PCOS) and endometriosis. Applied primarily by women's health segments, the expansion of these pharmaceuticals spans healthcare providers, retail pharmacies, and online platforms. End-use scope ranges from individual users, who prioritize ease and privacy, to healthcare systems focusing on comprehensive women's health services.

KEY MARKET STATISTICS
Base Year [2023] USD 17.33 billion
Estimated Year [2024] USD 18.36 billion
Forecast Year [2030] USD 27.41 billion
CAGR (%) 6.76%

Key growth influencers include increased awareness and acceptance of contraceptives, shifts in societal norms supporting family planning, and the burgeoning demand for more personalized medicine. Innovations focusing on minimizing side effects, extending the duration of effectiveness, or offering non-oral alternatives present significant opportunities. Companies should capitalize on technological advancements in the digital health space, offering platforms for virtual consultations and personalized medicine. Emerging markets, particularly in developing regions with increasing urbanization and better access to health education, offer untapped potential. Strategic alliances with healthcare bodies further streamline market penetration and consumer trust.

However, the market faces constraints such as ethical and political opposition in certain regions, potential health risks associated with long-term use, and side effects that can deter users. Regulatory hurdles also pose significant challenges, with stringent approvals often delaying product releases. Research into non-hormonal contraceptive options and furthering understanding of hormone impacts on diverse populations opens avenues for innovation. Lastly, shifting towards sustainability and environmental responsibility, such as developing biodegradable packaging, aligns with global environmental trends and opens new market niches. Balanced growth requires navigating these complexities while keeping pace with technological and regulatory evolutions. Understanding consumer feedback and adjusting strategies accordingly can vastly enhance market position and forecasted growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Oral Contraceptive Pills Market

The Oral Contraceptive Pills Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising adoption owing to unintended pregnancies
    • Government and NGO initiatives to promote contraceptive pills
    • Increasing prevalence of sexually transmitted diseases (STDs)
  • Market Restraints
    • Adverse health impacts of contraceptive pills
  • Market Opportunities
    • Advancements in the formulations of oral contraceptive pills
    • Improving access to birth control with telehealth services and favourable government approvals
  • Market Challenges
    • Safety and social concerns regarding pill usage and issues with product marketing

Porter's Five Forces: A Strategic Tool for Navigating the Oral Contraceptive Pills Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Oral Contraceptive Pills Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Oral Contraceptive Pills Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Oral Contraceptive Pills Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Oral Contraceptive Pills Market

A detailed market share analysis in the Oral Contraceptive Pills Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Oral Contraceptive Pills Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Oral Contraceptive Pills Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Oral Contraceptive Pills Market

A strategic analysis of the Oral Contraceptive Pills Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Oral Contraceptive Pills Market, highlighting leading vendors and their innovative profiles. These include Abbvie Inc., Acme Generics Pvt. Ltd., Afaxys, Inc., Agile Therapeutics, Inc., Amneal Pharmaceuticals LLC, Aurobindo Pharma Limited, Azesto Impex Private Limited, Bayer AG, HLL Lifecare Limited, Insud Pharma, Johnson & Johnson Services, Inc., Lupin Limited, Mankind Pharma Ltd., Mayne Pharma Group Limited, Merck & Co. Inc., Mithra Pharmaceuticals, SA, Mylan N.V., Perrigo Company PLC, Pfizer Inc., Piramal Pharma Solutions, Sanofi SA, Syzygy Healthcare Solutions LLC, Teva Pharmaceuticals Industries Ltd., TherapeuticsMD, Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Oral Contraceptive Pills Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Combination Pill, Continuous/Extended Pill, and Progesterone Pill.
  • Based on Age Group, market is studied across 15-24, 25-34, 35-44, and 45 and Above.
  • Based on Category, market is studied across Branded and Generic.
  • Based on Distribution, market is studied across Offline and Online.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising adoption owing to unintended pregnancies
      • 5.1.1.2. Government and NGO initiatives to promote contraceptive pills
      • 5.1.1.3. Increasing prevalence of sexually transmitted diseases (STDs)
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse health impacts of contraceptive pills
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in the formulations of oral contraceptive pills
      • 5.1.3.2. Improving access to birth control with telehealth services and favourable government approvals
    • 5.1.4. Challenges
      • 5.1.4.1. Safety and social concerns regarding pill usage and issues with product marketing
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Oral Contraceptive Pills Market, by Type

  • 6.1. Introduction
  • 6.2. Combination Pill
  • 6.3. Continuous/Extended Pill
  • 6.4. Progesterone Pill

7. Oral Contraceptive Pills Market, by Age Group

  • 7.1. Introduction
  • 7.2. 15-24
  • 7.3. 25-34
  • 7.4. 35-44
  • 7.5. 45 and Above

8. Oral Contraceptive Pills Market, by Category

  • 8.1. Introduction
  • 8.2. Branded
  • 8.3. Generic

9. Oral Contraceptive Pills Market, by Distribution

  • 9.1. Introduction
  • 9.2. Offline
  • 9.3. Online

10. Americas Oral Contraceptive Pills Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Oral Contraceptive Pills Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Oral Contraceptive Pills Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbvie Inc.
  • 2. Acme Generics Pvt. Ltd.
  • 3. Afaxys, Inc.
  • 4. Agile Therapeutics, Inc.
  • 5. Amneal Pharmaceuticals LLC
  • 6. Aurobindo Pharma Limited
  • 7. Azesto Impex Private Limited
  • 8. Bayer AG
  • 9. HLL Lifecare Limited
  • 10. Insud Pharma
  • 11. Johnson & Johnson Services, Inc.
  • 12. Lupin Limited
  • 13. Mankind Pharma Ltd.
  • 14. Mayne Pharma Group Limited
  • 15. Merck & Co. Inc.
  • 16. Mithra Pharmaceuticals, SA
  • 17. Mylan N.V.
  • 18. Perrigo Company PLC
  • 19. Pfizer Inc.
  • 20. Piramal Pharma Solutions
  • 21. Sanofi SA
  • 22. Syzygy Healthcare Solutions LLC
  • 23. Teva Pharmaceuticals Industries Ltd.
  • 24. TherapeuticsMD, Inc.
  • 25. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. ORAL CONTRACEPTIVE PILLS MARKET RESEARCH PROCESS
  • FIGURE 2. ORAL CONTRACEPTIVE PILLS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ORAL CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ORAL CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ORAL CONTRACEPTIVE PILLS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ORAL CONTRACEPTIVE PILLS MARKET DYNAMICS
  • TABLE 7. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CONTINUOUS/EXTENDED PILL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY PROGESTERONE PILL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY 15-24, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY 25-34, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY 35-44, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY 45 AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY BRANDED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 190. ORAL CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. ORAL CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, 2023